{"DataElement":{"publicId":"13382770","version":"1","preferredName":"Disease or Disorder Staging System Name","preferredDefinition":"The words by which the systematic method for clinicopathologic evaluation of tumors is known.","longName":"13381591v1.00:13362445v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13381591","version":"1","preferredName":"Disease or Disorder Staging System","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A systematic method for clinicopathologic evaluation of tumors.","longName":"2404658v1.00:2607511v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2607511","version":"1","preferredName":"Staging System","preferredDefinition":"A systematic method for clinicopathologic evaluation of tumors.","longName":"C18004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Staging System","conceptCode":"C18004","definition":"A systematic method for clinicopathologic evaluation of tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AF1F86D-DC61-6AF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-05","endDate":null,"createdBy":"UMLLOADER_CTOM","dateCreated":"2007-03-05","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9B6AE2E-EECA-20B3-E053-731AD00AA622","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-19","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":"4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13362445","version":"1","preferredName":"Staging System Name","preferredDefinition":"A systematic method for clinicopathologic evaluation of tumors._The words or language units by which a thing is known.","longName":"13362445v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"COG","valueDescription":null,"ValueMeaning":{"publicId":"2563903","version":"1","preferredName":"Children's Oncology Group","longName":"2563903v1.00","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SOKKERL","dateModified":"2023-03-01","changeDescription":"Updated to use Current concept C39353 - this one was retired in EVS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E1-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"FIGO","valueDescription":null,"ValueMeaning":{"publicId":"13367962","version":"1","preferredName":"Federation of Gynecology and Obstetrics","longName":"13367962v1.00","preferredDefinition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F98A1FAF-47DE-4A9B-E053-731AD00A04A6","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E2-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"AJCC","valueDescription":null,"ValueMeaning":{"publicId":"2647206","version":"1","preferredName":"American Joint Committee on Cancer","longName":"2647206","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"322D8245-A231-0462-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E3-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ann Arbor","valueDescription":null,"ValueMeaning":{"publicId":"2876478","version":"1","preferredName":"Ann Arbor","longName":"2876478","preferredDefinition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Lymphoma Staging System","conceptCode":"C54179","definition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69E46E87-968C-9211-E040-BB89AD4346ED","latestVersionIndicator":"Yes","beginDate":"2009-05-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E4-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"INSS","valueDescription":null,"ValueMeaning":{"publicId":"13367963","version":"1","preferredName":"International Neuroblastoma Staging System","longName":"13367963v1.00","preferredDefinition":"A surgicopathological staging system for neuroblastoma, based on the Evans staging system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Staging System","conceptCode":"C85416","definition":"A surgicopathological staging system for neuroblastoma, based on the Evans staging system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F98A1FAF-47DF-4A9B-E053-731AD00A04A6","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E5-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"INRGSS","valueDescription":null,"ValueMeaning":{"publicId":"13367964","version":"1","preferredName":"International Neuroblastoma Risk Group Staging System","longName":"13367964v1.00","preferredDefinition":"A clinical staging system for neuroblastoma based on preoperative imaging and determined prior to any treatment, including surgery. It includes two stages of localized disease (L1 and L2) and two stages of metastatic disease (M and MS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Risk Group Staging System","conceptCode":"C133427","definition":"A clinical staging system for neuroblastoma based on preoperative imaging and determined prior to any treatment, including surgery. It includes two stages of localized disease (L1 and L2) and two stages of metastatic disease (M and MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F98A1FAF-47E0-4A9B-E053-731AD00A04A6","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E6-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"EVANS","valueDescription":null,"ValueMeaning":{"publicId":"7797898","version":"1","preferredName":"Evans et al Tumor Regression Grade (1992)","longName":"7797898","preferredDefinition":"A grading system developed by Evans et al (1992) to assess a decrease in tumor size or extent in the body. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. (1992) 127:1335-9.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Evans et al Tumor Regression Grade (1992)","conceptCode":"C181469","definition":"A grading system developed by Evans et al (1992) to assess a decrease in tumor size or extent in the body. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. (1992) 127:1335-9.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE2B13F8-7790-5F17-E053-4EBD850ACF75","latestVersionIndicator":"Yes","beginDate":"2021-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-12","modifiedBy":"ONEDATA","dateModified":"2021-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E7-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E8-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F98A1FAF-47E9-4A9B-E053-731AD00A04A6","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Chang Staging","valueDescription":null,"ValueMeaning":{"publicId":"13570016","version":"1","preferredName":"Modified Chang Staging System for Medulloblastoma","longName":"13570016v1.00","preferredDefinition":"A classification system for the staging of medulloblastomas based on tumor size and location of metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Chang Staging System for Medulloblastoma","conceptCode":"C198826","definition":"A classification system for the staging of medulloblastomas based on tumor size and location of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB83F21B-7175-0C9C-E053-731AD00A1DAC","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-12","modifiedBy":"COLBERTM","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB83F21B-7176-0C9C-E053-731AD00A1DAC","beginDate":"2023-05-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-12","modifiedBy":"COLBERTM","dateModified":"2023-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13362444","version":"1","preferredName":"Staging System Name","preferredDefinition":"A systematic method for clinicopathologic evaluation of tumors._The words or language units by which a thing is known.","longName":"13362444v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Staging System","conceptCode":"C18004","definition":"A systematic method for clinicopathologic evaluation of tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F97AF9F0-58AD-2AEB-E053-731AD00A5D52","latestVersionIndicator":"Yes","beginDate":"2023-04-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-16","modifiedBy":"COLBERTM","dateModified":"2023-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F97AF9F0-58AE-2AEB-E053-731AD00A5D52","latestVersionIndicator":"Yes","beginDate":"2023-04-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-16","modifiedBy":"COLBERTM","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":"4/16/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173178","version":"1","longName":"Disease Attributes","context":"Pediatric Cancer"},{"publicId":"12173198","version":"1","longName":"Staging","context":"Pediatric Cancer"}]},{"publicId":"13954630","version":"1","longName":"All Pediatric Core CDEs","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"14599256","version":"1","longName":"Clinical Observation","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"STAGE_SYSTEM","type":"PCDC Alt Name","context":"Pediatric Cancer"},{"name":"Stage System","type":"Ped Cancer Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Stage System","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9B89B5D-602B-7C5F-E053-731AD00AE41E","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-19","modifiedBy":"FINCHAMB","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2/22/24 Added Ped Core Alts, CSI per PCDC/MW recommendations. BF;4/19/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}